Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 1575130, 8 pages
http://dx.doi.org/10.1155/2016/1575130
Review Article

Obstructive Form of Hypertrophic Cardiomyopathy-Left Ventricular Outflow Tract Gradient: Novel Methods of Provocation, Monitoring of Biomarkers, and Recent Advances in the Treatment

2nd Department of Cardiology, Jagiellonian University Collegium Medicum, Kopernika Street 17, 31-501 Cracow, Poland

Received 25 November 2015; Revised 17 March 2016; Accepted 6 April 2016

Academic Editor: Giovanni Di Salvo

Copyright © 2016 Pawel Petkow Dimitrow and Renata Rajtar-Salwa. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. C. Brock, “Functional obstruction of the left ventricle (acquired aortic subvalvar stenosis),” Guy's Hospital Reports, vol. 106, no. 4, pp. 221–238, 1957. View at Google Scholar
  2. A. G. Morrow and E. Braunwald, “Functional aortic stenosis; a malformation characterized by resistance,” Circulation, vol. 20, no. 2, pp. 181–189, 1959. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Braunwald, A. G. Morrow, W. P. Cornell, M. M. Aygen, and T. F. Hilbish, “Idiopathic hypertrophic subaortic stenosis: clinical, hemodynamic and angiographic manifestations,” The American Journal of Medicine, vol. 29, no. 6, pp. 924–945, 1960. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Braunwald, E. C. Brockenbrough, and A. G. Morrow, “Hypertrophic subaortic stenosis—a broadened concept,” Circulation, vol. 26, no. 2, pp. 161–165, 1962. View at Google Scholar
  5. E. Braunwald and M. M. Aygen, “Idiopathic myocardial hypertrophy without congestive heart failure or obstruction to blood flow. clinical, hemodynamic and angiocardiographic studies in fourteen patients,” The American Journal of Medicine, vol. 35, no. 1, pp. 7–19, 1963. View at Publisher · View at Google Scholar · View at Scopus
  6. P. M. Shah, R. Gramiak, and D. H. Kramer, “Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy,” Circulation, vol. 40, no. 1, pp. 3–11, 1969. View at Publisher · View at Google Scholar · View at Scopus
  7. A. S. Abbasi, R. N. MacAlpin, L. M. Eber, and M. L. Pearce, “Echocardiographic diagnosis of idiopathic hypertrophic cardiomyopathy without outflow obstruction,” Circulation, vol. 46, no. 5, pp. 897–904, 1972. View at Publisher · View at Google Scholar · View at Scopus
  8. W. L. Henry, C. E. Clark, and S. E. Epstein, “Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS.,” Circulation, vol. 47, no. 2, pp. 225–233, 1973. View at Publisher · View at Google Scholar · View at Scopus
  9. P. P. Dimitrow, D. Czarnecka, K. Kawecka-Jaszcz, and J. S. Dubiel, “The influence of age on gender-specific differences in the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy,” International Journal of Cardiology, vol. 88, no. 1, pp. 11–16, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. S. Maron, I. Olivotto, A. G. Zenovich et al., “Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction,” Circulation, vol. 114, no. 21, pp. 2232–2239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Jeanrenaud, J.-J. Goy, and L. Kappenberger, “Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy,” The Lancet, vol. 339, no. 8805, pp. 1318–1323, 1992. View at Publisher · View at Google Scholar · View at Scopus
  12. U. Sigwart, “Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy,” The Lancet, vol. 346, no. 8969, pp. 211–214, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Braunwald and P. A. Ebert, “Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs,” The American Journal of Cardiology, vol. 10, no. 4, pp. 489–495, 1962. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Braunwald, C. T. Lambrew, S. D. Rockoff, J. Ross, and A. G. Morrow, “Idiopathic hypertrophic subaortic stenosis: I. A description of the disease based upon an analysis of 64 patients,” Circulation, vol. 29, supplement 4, pp. 3–119, 1964. View at Google Scholar
  15. D. M. Gilligan, W. L. Chan, E. L. Ang, and C. M. Oakley, “Effects of a meal on hemodynamic function at rest and during exercise in patients with hypertrophic cardiomyopathy,” Journal of the American College of Cardiology, vol. 18, no. 2, pp. 429–436, 1991. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Paz, R. Jortner, P. A. Tunick et al., “The effect of the ingestion of ethanol on obstruction of the left ventricular outflow tract in hypertrophic cardiomyopathy,” The New England Journal of Medicine, vol. 335, no. 13, pp. 938–941, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. E. D. Wigle, S. C. Lenkei, A. Chrysohou, and D. R. Wilson, “Muscular subaortic stenosis: the effect of peripheral vasodilatation,” Canadian Medical Association Journal, vol. 89, pp. 896–899, 1963. View at Google Scholar · View at Scopus
  18. P. P. Dimitrow, C. Cotrim, and T. O. Cheng, “Need for a standardized protocol for stress echocardiography in provoking subaortic and valvular gradient in various cardiac conditions,” Cardiovascular Ultrasound, vol. 12, article 26, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Chun and A. Woo, “Echocardiography in hypertrophic cardiomyopathy: In with strain, out with straining?” Journal of the American Society of Echocardiography, vol. 28, no. 2, pp. 204–209, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. J. S. Shah, M. T. T. Esteban, R. Thaman et al., “Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy,” Heart, vol. 94, no. 10, pp. 1288–1294, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. P. P. Dimitrow, M. Bober, J. Michałowska, and D. Sorysz, “Left ventricular outflow tract gradient provoked by upright position or exercise in treated patients with hypertrophic cardiomyopathy without obstruction at rest,” Echocardiography, vol. 26, no. 5, pp. 513–520, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Schwammenthal, B. Schwartzkopff, M. Block et al., “Doppler echocardiographic assessment of the pressure gradient during bicycle ergometry in hypertrophic cardiomyopathy,” The American Journal of Cardiology, vol. 69, no. 19, pp. 1623–1628, 1992. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Cotrim, M. J. Loureiro, O. Simões et al., “Evaluation of hypertrophic obstructive cardiomyopathy by exercise stress echocardiography: new methodology,” Revista Portuguesa de Cardiologia, vol. 24, no. 11, pp. 1319–1327, 2005. View at Google Scholar · View at Scopus
  24. P. P. Dimitrow and T. O. Cheng, “Standing position alone or in combination with exercise as a stress test to provoke left ventricular outflow tract gradient in hypertrophic cardiomyopathy and other conditions,” International Journal of Cardiology, vol. 143, no. 3, pp. 219–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Cotrim, I. João, P. Fazendas et al., “Clinical applications of exercise stress echocardiography in the treadmill with upright evaluation during and after exercise,” Cardiovascular Ultrasound, vol. 11, article 26, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. C. A. Wittlieb-Weber, M. S. Cohen, M. G. McBride et al., “Elevated left ventricular outflow tract velocities on exercise stress echocardiography may be a normal physiologic response in healthy youth,” Journal of the American Society of Echocardiography, vol. 26, no. 12, pp. 1372–1378, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. C. A. Wittlieb-Weber, M. S. Cohen, M. G. McBride, S. M. Paridon, and P. Stephens Jr., “Authors’ reply,” Journal of the American Society of Echocardiography, vol. 27, no. 3, pp. 341–342, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Miranda, C. Cotrim, N. Cardim et al., “Evaluation of left ventricular outflow tract gradient during treadmill exercise and in recovery period in orthostatic position, in patients with hypertrophic cardiomyopathy,” Cardiovascular Ultrasound, vol. 6, article 19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Peteiro, A. Bouzas-Mosquera, X. Fernandez et al., “Prognostic value of exercise echocardiography in patients with hypertrophic cardiomyopathy,” Journal of the American Society of Echocardiography, vol. 25, no. 2, pp. 182–189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Nistri, I. Olivotto, M. S. Maron et al., “Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy,” The American Journal of Cardiology, vol. 106, no. 9, pp. 1301–1306, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Y. Desai, A. Bhonsale, P. Patel et al., “Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes,” JACC: Cardiovascular Imaging, vol. 7, no. 1, pp. 26–36, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Feiner, M. Arabadjian, G. Winson, B. Kim, F. Chaudhry, and M. V. Sherrid, “Post-prandial upright exercise echocardiography in hypertrophic cardiomyopathy,” Journal of the American College of Cardiology, vol. 61, no. 24, pp. 2487–2488, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Zemanek, P. Tomasov, M. Bělehrad et al., “Comparison of sublingual isosorbide dinitrate and Valsalva maneuver for detection of obstruction in hypertrophic cardiomyopathy,” Archives of Medical Science, vol. 11, no. 4, pp. 751–755, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. L. R. Lopes, C. Cotrim, I. Cruz, E. Picano, F. Pinto, and H. Pereira, “Left ventricular outflow tract obstruction as a primary phenotypic expression of hypertrophic cardiomyopathy in mutation carriers without hypertrophy,” International Journal of Cardiology, vol. 176, no. 3, pp. 1264–1267, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Miwa, K. Soejima, T. Sato et al., “Dramatic improvement of refractory anemia caused by mechanical hemolysis in a patient with hypertrophic obstructive cardiomyopathy using dual-chamber pacing,” Journal of Arrhythmia, vol. 31, no. 4, pp. 243–245, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Kubo, T. Okumiya, Y. Baba et al., “Erythrocyte creatine as a marker of intravascular hemolysis due to left ventricular outflow tract obstruction in hypertrophic cardiomyopathy,” Journal of Cardiology, vol. 67, no. 3, pp. 274–278, 2016. View at Publisher · View at Google Scholar
  37. P. P. Dimitrow, A. Undas, M. Bober, W. Tracz, and J. S. Dubiel, “Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation,” Heart, vol. 94, no. 6, p. e21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Le Tourneau, S. Susen, C. Caron et al., “Functional impairment of von willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction,” Circulation, vol. 118, no. 15, pp. 1550–1557, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. J. L. Blackshear, M. E. Stark, R. C. Agnew et al., “Remission of recurrent gastrointestinal bleeding after septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy-associated acquired von Willebrand syndrome,” Journal of Thrombosis and Haemostasis, vol. 13, no. 2, pp. 191–196, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. J. L. Blackshear, H. Kusumoto, R. E. Safford et al., “Usefulness of von willebrand factor activity indexes to predict therapeutic response in hypertrophic cardiomyopathy,” The American Journal of Cardiology, vol. 117, no. 3, pp. 436–442, 2016. View at Publisher · View at Google Scholar
  41. H. S. Hvid-Jensen, S. H. Poulsen, and J. S. Agnholt, “Severe gastrointestinal bleeding in a patient with subvalvular aortic stenosis treated with thalidomide and octreotide: bridging to transcoronary ablation of septal hypertrophy,” Journal of Clinical Medicine Research, vol. 7, no. 11, pp. 907–910, 2015. View at Publisher · View at Google Scholar
  42. P. P. Dimitrow, A. Undas, P. Wołkow, W. Tracz, and J. S. Dubiel, “Enhanced oxidative stress in hypertrophic cardiomyopathy,” Pharmacological Reports, vol. 61, no. 3, pp. 491–495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. P. P. Dimitrow, A. Undas, M. Bober, W. Tracz, and J. S. Dubiel, “Plasma biomarkers of endothelial dysfunction in patients with hypertrophic cardiomyopathy,” Pharmacological Reports, vol. 59, no. 6, pp. 715–720, 2007. View at Google Scholar · View at Scopus
  44. C. Zhang, R. Liu, J. Yuan et al., “Significance and determinants of cardiac troponin I in patients with obstructive hypertrophic cardiomyopathy,” American Journal of Cardiology, vol. 116, no. 11, pp. 1744–1751, 2015. View at Publisher · View at Google Scholar
  45. S. Nakamura, H. Takano, J. Matsuda et al., “Prognostic values of highly sensitive cardiac troponin T and B-type natriuretic peptide for clinical features in hypertrophic obstructive cardiomyopathy: a cross-sectional study,” BMJ Open, vol. 4, no. 9, Article ID e005968, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Zhang, R. Liu, J. Yuan et al., “Predictive values of N-terminal pro-B-type natriuretic peptide and cardiac troponin I for myocardial fibrosis in hypertrophic obstructive cardiomyopathy,” PLoS ONE, vol. 11, no. 1, Article ID e0146572, 2016. View at Publisher · View at Google Scholar
  47. M. V. Sherrid, “Pharmacologic therapy of hypertrophic cardiomyopathy,” Current Cardiology Reviews. In press.
  48. A. Jurado Román, J. M. Montero Cabezas, B. Rubio Alonso et al., “Sequential atrioventricular pacing in patients with hypertrophic cardiomyopathy: an 18-year experience,” Revista Española de Cardiología, vol. 69, no. 4, pp. 377–383, 2015. View at Publisher · View at Google Scholar
  49. M. Liebregts, P. A. Vriesendorp, B. K. Mahmoodi, A. F. Schinkel, M. Michels, and J. M. ten Berg, “A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy,” JACC: Heart Failure, vol. 3, no. 11, pp. 896–905, 2015. View at Publisher · View at Google Scholar
  50. K. Singh, M. Qutub, K. Carson, B. Hibbert, and C. Glover, “A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy,” Catheterization and Cardiovascular Interventions, 2015. View at Publisher · View at Google Scholar
  51. J. Veselka, J. Krejčí, P. Tomašov, and D. Zemánek, “Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population,” European Heart Journal, vol. 35, no. 30, pp. 2040–2045, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Veselka, T. Lawrenz, C. Stellbrink et al., “Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a European multicenter and multinational study,” Catheterization and Cardiovascular Interventions, vol. 84, no. 1, pp. 101–107, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Veselka, M. K. Jensen, M. Liebregts et al., “Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry,” European Heart Journal, 2016. View at Publisher · View at Google Scholar
  54. M. Liebregts, R. C. Steggerda, P. A. Vriesendorp et al., “Long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in the young and the elderly,” JACC: Cardiovascular Interventions, vol. 9, no. 5, pp. 463–469, 2016. View at Publisher · View at Google Scholar
  55. L. K. Williams, R. H. Chan, S. Carasso et al., “Effect of left ventricular outflow tract obstruction on left atrial mechanics in hypertrophic cardiomyopathy,” BioMed Research International, vol. 2015, Article ID 481245, 10 pages, 2015. View at Publisher · View at Google Scholar
  56. E. Quintana, H. V. Schaff, and J. A. Dearani, “Transapical myectomy for septal hypertrophy not accessible through the aortic root,” World Journal for Pediatric and Congenital Heart Surgery, vol. 6, no. 3, pp. 455–457, 2015. View at Publisher · View at Google Scholar
  57. K. C. Ong, J. B. Geske, H. V. Schaff, and R. A. Nishimura, “Transapical myectomy for severe mid-ventricular obstructive hypertrophic cardiomyopathy,” European Heart Journal, vol. 35, no. 39, p. 2713, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Ferrazzi, P. Spirito, A. Iacovoni et al., “Transaortic chordal cutting: mitral valve repair for obstructive hypertrophic cardiomyopathy with mild septal hypertrophy,” Journal of the American College of Cardiology, vol. 66, no. 15, pp. 1687–1696, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Dulguerov, C. Marcacci, C. Alexandrescu, K. J. Chan, and G. D. Dreyfus, “Hypertrophic obstructive cardiomyopathy: the mitral valve could be the key,” European Journal of Cardio-Thoracic Surgery, 2016. View at Publisher · View at Google Scholar
  60. U. Schäfer, F. Kreidel, and C. Frerker, “MitraClip implantation as a new treatment strategy against systolic anterior motion-induced outflow tract obstruction in hypertrophic obstructive cardiomyopathy,” Heart Lung and Circulation, vol. 23, no. 5, pp. e131–e135, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Alkhouli, “Will the Mitral Clip become the invasive treatment of choice for hypertrophic obstructive cardiomyopathy?” Postepy w Kardiologii Interwencyjnej, vol. 10, no. 3, pp. 153–154, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. U. Schäfer, C. Frerker, T. Thielsen et al., “Targeting systolic anterior motion and left ventricular outflow tract obstruction in hypertrophic obstructed cardiomyopathy with a MitraClip,” EuroIntervention, vol. 11, no. 8, pp. 942–947, 2015. View at Publisher · View at Google Scholar
  63. T. Isawa, N. Tada, T. Ootomo, M. Sakurai, K. Takizawa, and N. Inoue, “Transradial approach of alcohol septal ablation using a sheathless guiding catheter: a feasibility study,” Journal of Invasive Cardiology, vol. 27, no. 11, pp. E242–E247, 2015. View at Google Scholar
  64. M. Kitamura, M. Takayama, J. Matsuda et al., “Clinical characteristics and outcome of alcohol septal ablation with confirmation by nitroglycerin test for drug-refractory hypertrophic obstructive cardiomyopathy with labile left ventricular outflow obstruction,” The American Journal of Cardiology, vol. 116, no. 6, Article ID 21252, pp. 945–951, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. E. Durand, E. Mousseaux, P. Coste et al., “Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up,” European Heart Journal, vol. 29, no. 3, pp. 348–355, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. S. Okutucu, K. Aytemir, and A. Oto, “Glue septal ablation: a promising alternative to alcohol septal ablation,” JRSM Cardiovascular Disease, vol. 5, 2016. View at Publisher · View at Google Scholar
  67. Y. Maekawa, M. Jinzaki, H. Tsuruta et al., “Improved renal function in a patient with hypertrophic obstructive cardiomyopathy after multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation,” International Journal of Cardiology, vol. 181, pp. 349–350, 2015. View at Publisher · View at Google Scholar
  68. R. M. Cooper, A. Shahzad, J. Hasleton et al., “Radiofrequency ablation of the 3for obstructive hypertrophic cardiomyopathy with mild septal hypertrophy,” Journal of the American College of Cardiology, vol. 66, no. 15, pp. 1687–1696, 2015. View at Publisher · View at Google Scholar
  69. S. Magage, A. Linhart, J. Bultas et al., “Fabry disease: percutaneous transluminal septal myocardial ablation markedly improved symptomatic left ventricular hypertrophy and outflow tract obstruction in a classically affected male,” Echocardiography, vol. 22, no. 4, pp. 333–339, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. R. T. Murphy, N. B. Ratliff, H. M. Lever, and S. R. Kapadia, “Use of percutaneous transluminal septal myocardial ablation for relief of outflow tract obstruction in cardiac amyloidosis: a novel therapeutic target,” Catheterization and Cardiovascular Interventions, vol. 68, no. 4, pp. 637–641, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. J. T. Poterucha, J. N. Johnson, P. W. O'Leary et al., “Surgical ventricular septal myectomy for patients with noonan syndrome and symptomatic left ventricular outflow tract obstruction,” American Journal of Cardiology, vol. 116, no. 7, pp. 1116–1121, 2015. View at Publisher · View at Google Scholar · View at Scopus
  72. H. N. Anderson, H. M. Burkhart, and J. N. Johnson, “Septal myectomy for hypertrophic obstructive cardiomyopathy in Friedreich's ataxia,” Cardiology in the Young, vol. 26, no. 1, pp. 175–178, 2016. View at Publisher · View at Google Scholar
  73. Authors/Task Force Members, P. M. Elliott, A. Anastasakis et al., “2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC),” European Heart Journal, vol. 35, no. 39, pp. 2733–2779, 2014. View at Publisher · View at Google Scholar